Clinical Trial: Assessment of Wall Thickness in Hypertrophic Cardiomyopathy
Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Observational
Official Title: Assessment of Wall Thickness in Hypertrophic Cardiomyopathy
Brief Summary: Assessment of wall thickness in hypertrophic cardiomyopathy (HCM) is of diagnostic and prognostic importance given its known association with sudden cardiac death. However, data regarding comparison of imaging modalities for this key measurement is lacking. This study seeks to compare assessment of maximum wall thickness between clinically indicated echocardiography (with and without contrast) and clinically indicated cardiac magnetic resonance imaging.
Detailed Summary: Patients receiving clinically indicated echocardiograms and cardiac magnetic resonance imaging at Mayo Clinic will be eligible.
Sponsor: Mayo Clinic
Current Primary Outcome: Left Ventricular Wall Thickness [ Time Frame: approximately 1 week after enrollment ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Mayo Clinic
Dates:
Date Received: September 5, 2014
Date Started: October 2014
Date Completion: March 2017
Last Updated: September 26, 2016
Last Verified: September 2016